Finished
Study on the Performance of Symmcora® Mid-term Suture Versus Novosyn® Suture in Patients Undergoing Robotic Assisted Gastric Bypass Surgery
NCT05433688 · Aesculap AG · Updated 29 June 2026
- What is being tested
- Robotic assisted gastric bypass surgery
- For
- Adiposity
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 150 people. The full rules are on the registry page.
- Where
- Germany
- When
- Starts or started 12 Oct 2022, ends 11 March 2026. Registered 27 June 2022.
- Results
- None posted yet.
In the researchers' words
The study is designed as a prospective, mono-centric, randomized, patient blinded comparison of unidirectional barbed suture (Symmcora® mid term, UBS) vs. a conventional suture (Novosyn®, CS). Patient will be randomly allocated in a 1:1 ratio to either the UBS group or the CS group to perform the gastro-jejunal anastomosis (GJA) and the jejuno-jejunal anastomosis (JJA). The product under investigation and the conventional suture material will be used in routine clinical practice and according to the Instructions for Use (IfU).
Sites
- Universitätsklinikum Schleswig-HolsteinKiel, Schleswig-Holstein, Germany